Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 40 - State Medical Board › Article 6 - General Provisions › 12 AAC 40.983 - Cooperative practice agreements with pharmacists

Current through May 31, 2024
(a) A physician may
				  enter into a cooperative practice agreement with a pharmacist licensed under AS
				  08.80 as provided in this section. The initial agreement may not exceed two
				  years and is subject to renewal under (j) of this section.
(b) A physician planning to enter into a
				  cooperative practice agreement with a pharmacist must submit to the board a
				  written proposed agreement that meets the requirements of this section. The
				  proposed agreement must be approved by the board before cooperative practice
				  under the agreement, if approved, begins. A proposed modification to an
				  agreement must be submitted to the board for approval, before the modification,
				  if approved, is implemented. The board will approve a proposed agreement or
				  modification if it is medically appropriate and provides for the safety of the
				  patient. If the board disapproves a proposed agreement or modification, the
				  board shall state the reasons for its action.
(c) A cooperative practice agreement between
				  a physician and a pharmacist must include
(1)
				  the physician's authorization to a pharmacist or group of pharmacists to manage
				  a patient's medication therapy;
(2)
				  the full name, medical license number, date of issuance of license, and
				  specialty, if any, of each physician who is a party to the agreement;
(3) the full name, place of employment,
				  mailing address, pharmacist license number, and date of issuance of license, of
				  each pharmacist who is a party to the agreement;
(4) a statement of the duration of the
				  agreement, which may not exceed two years;
(5) the types of cooperative practice
				  decisions that the physician is authorizing the pharmacist to make under the
				  agreement, including
(A) types of diseases,
				  medications, or medication categories involved and the type of cooperative
				  authority to be exercised in each case; and
(B) procedures, decision criteria, or plans
				  the pharmacist must follow when making therapeutic decisions, particularly when
				  initiating or modifying medication;
(6) requirements that a pharmacist must
				  follow when exercising cooperative authority, including documentation of
				  decisions made, and a plan for communication and feedback to the physician
				  concerning specific decisions made;
(7) a plan for the physician to review the
				  decisions made by the pharmacist at least once every three months;
(8) a plan for providing to the physician
				  patient records created under the agreement;
(9) a provision that allows the physician to
				  override the agreement if the physician considers it medically necessary or
				  appropriate;
(10) an
				  acknowledgement that the physician will not receive any compensation from a
				  pharmacist or pharmacy as a result of the care or treatment of any patient
				  under the agreement;
(11) a
				  prohibition on the administration or dispensing of any schedule I, II, III, or
				  IV controlled substances.